Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...

In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ ... such as clinical history, genomes, and social determinants of health, to produce deeper insights that have ...

Today, the Chan Zuckerberg Initiative (CZI) launched the Billion Cells Project, an effort to generate an unprecedented one ...

CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular behavior and gene function.

EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...

This collaboration will use 10x Genomics' Chromium GEM-X technology ... omics sets at low costs," said Gilad Almogy, Founder and CEO of Ultima Genomics. "Initiatives like the Billion Cells Project ...